Literature DB >> 16750689

Effects of gender on peak oxygen consumption and the timing of cardiac transplantation.

Sammy Elmariah1, Lee R Goldberg, Michael T Allen, Andrew Kao.   

Abstract

OBJECTIVES: This study examines the gender effects on peak exercise oxygen consumption (VO2) and survival in heart failure (HF) patients and their implications for cardiac transplantation.
BACKGROUND: The predictive value of peak VO2 in women HF patients is poorly established but is one of the indicators used to optimally time cardiac transplantation in women.
METHODS: A total of 594 ambulatory HF patients (mean age 52 +/- 12 years, 28% women, mean left ventricular ejection fraction 26 +/- 12%, 73% on beta-blocker) underwent symptom-limited exercise tests with breath-by-breath expired gas analyses using ramped treadmill protocols. Kaplan-Meier survival curves were generated for each gender and compared using log-rank tests.
RESULTS: Women had a significantly lower peak VO2 than men (14.0 +/- 4.9 ml/kg/min vs. 16.6 +/- 7.1 ml/kg/min; p < 0.0001), despite being younger (48.9 +/- 11.5 years vs. 53.2 +/- 12.4 years; p < 0.0001) and having a higher left ventricular ejection fraction (29 +/- 13% vs. 25 +/- 11%; p < 0.0003). However, the one-year transplant-free survival was significantly lower for men than for women (81% vs. 94%, p < 0.0001), a finding seen across each Weber class. Cox regression analyses confirmed the protective effects of female gender on transplant-free survival when controlling for peak VO2, age, race, beta-blocker use, and type of cardiomyopathy. The peak VO2 associated with 85% one-year transplant-free survival was significantly higher in men than in women (11.5 vs. 10.0 ml/kg/min).
CONCLUSIONS: Women had a significantly lower peak Vo(2) than men, but had better survival at all levels of exercise capacity. The current practice of uniform application of peak VO2 as an aid to determine cardiac transplantation timing should be re-examined.

Entities:  

Mesh:

Year:  2006        PMID: 16750689     DOI: 10.1016/j.jacc.2005.11.089

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  15 in total

Review 1.  Heart failure in women.

Authors:  J Julia Shin; Eman Hamad; Sandhya Murthy; Ileana L Piña
Journal:  Clin Cardiol       Date:  2012-03       Impact factor: 2.882

Review 2.  The clinical and research applications of aerobic capacity and ventilatory efficiency in heart failure: an evidence-based review.

Authors:  Ross Arena; Jonathan Myers; Marco Guazzi
Journal:  Heart Fail Rev       Date:  2007-11-07       Impact factor: 4.214

3.  Imaging of cardiac sympathetic activity in heart failure: Not out of the woods yet.

Authors:  Catherine Gebhard
Journal:  J Nucl Cardiol       Date:  2017-01-18       Impact factor: 5.952

4.  Prognostic role of cardiac power index in ambulatory patients with advanced heart failure.

Authors:  Justin L Grodin; Wilfried Mullens; Matthias Dupont; Yuping Wu; David O Taylor; Randall C Starling; W H Wilson Tang
Journal:  Eur J Heart Fail       Date:  2015-04-28       Impact factor: 15.534

5.  Impact of gender on benefits of exercise training on sympathetic nerve activity and muscle blood flow in heart failure.

Authors:  Ligia M Antunes-Correa; Ruth C Melo; Thais S Nobre; Linda M Ueno; Fabio G M Franco; Ana M W Braga; Maria U P B Rondon; Patricia C Brum; Antonio C P Barretto; Holly R Middlekauff; Carlos E Negrao
Journal:  Eur J Heart Fail       Date:  2010-01       Impact factor: 15.534

6.  Variables Measured During Cardiopulmonary Exercise Testing as Predictors of Mortality in Chronic Systolic Heart Failure.

Authors:  Steven J Keteyian; Mahesh Patel; William E Kraus; Clinton A Brawner; Timothy R McConnell; Ileana L Piña; Eric S Leifer; Jerome L Fleg; Gordon Blackburn; Gregg C Fonarow; Paul J Chase; Lucy Piner; Marianne Vest; Christopher M O'Connor; Jonathan K Ehrman; Mary N Walsh; Gregory Ewald; Dan Bensimhon; Stuart D Russell
Journal:  J Am Coll Cardiol       Date:  2016-02-23       Impact factor: 24.094

7.  Baseline differences in the HF-ACTION trial by sex.

Authors:  Ileana L Piña; Peter Kokkinos; Andrew Kao; Vera Bittner; Matt Saval; Bob Clare; Lee Goldberg; Maryl Johnson; Ann Swank; Hector Ventura; Gordon Moe; Meredith Fitz-Gerald; Stephen J Ellis; Marianne Vest; Lawton Cooper; David Whellan
Journal:  Am Heart J       Date:  2009-10       Impact factor: 4.749

8.  The relationship between body mass index and cardiopulmonary exercise testing in chronic systolic heart failure.

Authors:  Tamara B Horwich; Eric S Leifer; Clinton A Brawner; Meredith B Fitz-Gerald; Gregg C Fonarow
Journal:  Am Heart J       Date:  2009-10       Impact factor: 4.749

Review 9.  Matching the Market for Heart Transplantation.

Authors:  Eileen M Hsich
Journal:  Circ Heart Fail       Date:  2016-04       Impact factor: 8.790

10.  Importance of treadmill exercise time as an initial prognostic screening tool in patients with systolic left ventricular dysfunction.

Authors:  Eileen Hsich; Eiran Z Gorodeski; Randall C Starling; Eugene H Blackstone; Hemant Ishwaran; Michael S Lauer
Journal:  Circulation       Date:  2009-06-15       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.